Cited by 16T-cell and B-cell ImmunologyPsoriasis: Treatment and PathogenesisCancer Immunotherapy and Biomarkers

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Treg Cells Survive and Thrive in Inhospitable Environments

Open access

Abstract

Immune responses are dangerous by nature and require regulation to prevent inflammatory and/or autoimmune sequelae and allow healing. CD4+Foxp3+ T cells (Treg cells) play a crucial role in this process, and in this edition of Cell Metabolism, Angelin et al. (2017) describe how these cells are metabolically adapted to the job.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.cmet.2017.05.012

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The majority of patients do not respond to checkpoint therapies as a result of heightened immunosuppression in the tumor microenvironment or inadequate non-self antigenic load within the tumor.

    “the majority of patients do not respond as a result of heightened immunosuppression in the tumor microenvironment or inadequate non-self antigenic load within the tumor”

    From LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer (2018) · cites this paper as Grzes et al., 2017

    No passage from our copy matched the claim. Searches for checkpoint-therapy nonresponse, tumor immunosuppression, and non-self antigenic load also returned no passages, so the attributed explanation cannot be verified from this copy. (LLM, conf=0.68)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Research works printed but not linked: 8

  1. Angelin, 2017, Cell Metab., 25, 1282, 10.1016/j.cmet.2016.12.018 · DOI
  2. De Rosa, 2015, Nat. Immunol., 16, 1174, 10.1038/ni.3269 · DOI
  3. Gandolfo, 2009, Kidney Int., 76, 717, 10.1038/ki.2009.259 · DOI
  4. Gerriets, 2016, Nat. Immunol., 17, 1459, 10.1038/ni.3577 · DOI
  5. Howie, 2017, JCI Insight, 2, e89160, 10.1172/jci.insight.89160 · DOI
  6. Michalek, 2011, J. Immunol., 186, 3299, 10.4049/jimmunol.1003613 · DOI · Paper page
  7. Preston, 2015, EMBO J., 34, 2008, 10.15252/embj.201490252 · DOI
  8. Wang, 2011, Immunity, 35, 871, 10.1016/j.immuni.2011.09.021 · DOI · Paper page

Cited by

Sorted by citations

  • LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer

    Tavazoie, M. F., Pollack, I., Tanqueco, R., Ostendorf, B. N., Reis, B. S., Gonsalves, F. C., Kurth, I., Andreu-Agullo, C., Derbyshire, M. L., Posada, J., et al. (2018) · Cell · doi:10.1016/j.cell.2017.12.026 · Cited by 476

    “Although the clinical responses to these therapies in multiple common cancer types can be remarkably prolonged, the majority of patients do not respond as a result of heightened immunosuppression in the tumor microenvironment or inadequate non-self-antigenic load within the tumor (Grzes et al., 2017; Sharma et al., 20…”

Metadata

Authors
Grzes, K. M., Field, C. S., & Pearce, E. J.
Affiliations
  • Max Planck Institute of Immunobiology and Epigenetics (DE)
  • University of Freiburg (DE)
Corresponding author
Pearce, Edward J.
Venue
Cell Metabolism
Publisher
Elsevier BV
Published
2017-06
Volume
25
Issue
6
Pages
1213-1215
ISSN
1550-4131 (ISSN-L)
OpenAlex
W2623945663
Cited by
16
References
2
Citations by year
2026: 2 · 2025: 2 · 2024: 1 · 2023: 1 · 2022: 4 · 2021: 2 · 2020: 1 · 2018: 3
FWCI
0.50
Type
journal article
Language
en
Open access
Locations
  • Cell Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
  • Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
Keywords
regulatory T cells, CD4+ Foxp3+ T cells, metabolic adaptation, immune regulation, inflammation, autoimmunity
MeSH terms
Glucose, CD4-Positive T-Lymphocytes, Lactic Acid, T-Lymphocytes, Regulatory, Forkhead Transcription Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review